Publications by authors named "R R Edelman"

Background: Luminal and hemodynamic evaluations of the cervical arteries inform the diagnosis and management of patients with cervical arterial disease.

Purpose: To demonstrate a 3D nonenhanced quantitative quiescent interval slice-selective (qQISS) magnetic resonance angiographic (MRA) strategy that provides simultaneous hemodynamic and luminal evaluation of the cervical arteries.

Study Type: Prospective.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to develop a non-contrast MRI/MRA protocol to evaluate kidney function and identify abnormalities in living kidney donors.
  • A total of 28 subjects underwent various imaging techniques, including pCASL and two MRA methods, to assess renal perfusion and visualize renal arteries.
  • The results indicated that the new protocol reliably assessed kidney function within 10 minutes, avoiding risks associated with contrast agents and radiation.
View Article and Find Full Text PDF

Background: Three-dimensional (3D) contrast-enhanced magnetic resonance angiography (CEMRA) is routinely used for vascular evaluation. With existing techniques for CEMRA, diagnostic image quality is only obtained during the first pass of the contrast agent or shortly thereafter, whereas angiographic quality tends to be poor when imaging is delayed to the equilibrium phase. We hypothesized that prolonged blood pool contrast enhancement could be obtained by imaging with a balanced T1 relaxation-enhanced steady-state (bT1RESS) pulse sequence, which combines 3D balanced steady-state free precession (bSSFP) with a saturation recovery magnetization preparation to impart T1 weighting and suppress background tissues.

View Article and Find Full Text PDF

Background: Dengue human infection models (DHIMs) are important tools to down-select dengue vaccine candidates and establish tetravalent efficacy before advanced clinical field trials. We aimed to provide data for the safety and immunogenicity of DHIM and evaluate dengue vaccine efficacy.

Methods: We performed an open-label, phase 1 trial at the University of Maryland (Baltimore, MD, USA).

View Article and Find Full Text PDF